Viewing Study NCT00744757


Ignite Creation Date: 2025-12-24 @ 6:49 PM
Ignite Modification Date: 2026-01-26 @ 7:56 PM
Study NCT ID: NCT00744757
Status: COMPLETED
Last Update Posted: 2013-09-09
First Post: 2008-08-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)
Sponsor: Johnson & Johnson Taiwan Ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None dacogen View
None 5-aza-2'-deoxycytidine View
None decitabine View
None Myelodysplastic Syndrome View